Bret Jensen
Contributor since: 2010
Company: The Biotech Forum
Latest Articles
Verastem: Undervalued And Derisked
Neos Therapeutics: The Road Ahead
Omeros: Head Fake Is Buying Opportunity
BioDelivery Sciences Continues To Roll
Progenics: Inflection Point In 2019
Aratana Therapeutics: Revisiting After Q3 Earnings
Exelixis: Going, Going, Gone
The Kids Will Be All Right
TG Therapeutics: What's Ahead For This Oncology Concern
Our Take On Clearside Biomedical
Revisiting Leap Therapeutics
Dynavax: An Updated Investment Analysis
2 PARP Concerns On The Move
An In-Depth Look At ObsEva
Navigating The 'Rate Rant'
Pieris Pharmaceuticals: Our Take On This $5 Biotech Stock
An Updated Investment View On Theravance Biopharma
Clovis Oncology: Some Positives Emerge
Revisiting Supernus Pharmaceuticals
Epizyme: An Updated Investment Thesis
Acadia Survives CNN 'Bear Attack'
Leap Therapeutics: An Updated Investment View
Exelixis: An Updated View
Xenon: An Updated Investment Analysis
Amarin: Buy This ~$3 Small Cap?
Galmed Pharmaceuticals: Buy This NASH Play?
Our First Look At Spero Therapeutics
Revisiting Cytosorbents
Dynavax Technologies: What Lies Ahead
Neos Therapeutics: Growth Story Remains Intact
Invitae: Growth Continues Unabated
Don't Give Up On Clovis